Tonix Pharmaceuticals Holding Corp (NAS:TNXP)
$ 0.1373 -0.0039 (-2.76%) Market Cap: 19.22 Mil Enterprise Value: 24.84 Mil PE Ratio: 0 PB Ratio: 0.03 GF Score: 30/100

Tonix Pharmaceuticals Holding Corp at Raymond James Human Health Innovation Conference (Virtual) Transcript

Jun 23, 2021 / 12:00PM GMT
Release Date Price: $7168 (+0.90%)
Matthew Karpf
Raymond James - Analyst

Good morning and welcome to the third day of the 2021 Raymond James Human Health Innovation Conference. My name is Matthew Karpf with Raymond James investment banking. I'm very lucky to be joined by Seth Lederman, Co-Founder, CEO, and Chairman of Tonix Pharmaceuticals. (Conference Instructions). Seth, handing it off to you.

Seth Lederman
Tonix Pharmaceuticals Holding Corp. - Co-Founder, CEO, and Chairman

Thank you very much, and thanks to the organizers for having us and thanks to everyone who is participating. I'm Seth Lederman, CEO of Tonix Pharmaceuticals. And I'd like to take you through our presentation this morning. (technical difficulty)

Tonix is on NASDAQ, our ticker is TNXP; and it is a very exciting time for Tonix. So, it's a good time, if you haven't been following us, to start watching. This is our standard Safe Harbor statement. We'll be making forward-looking statements and I refer you to our SEC documents, the 10-K and other documents for more complete information.

Tonix is a NASDAQ

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot